JG
UTHR icon

Jefferies Group’s United Therapeutics UTHR Stock Holding History

Jefferies Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,000
Closed -$2.68M – 2014
2021
Q1 		$2.68M Buy
+16,000
New +$2.67M 0.02% 576
2015
Q2 		– Sell
-26,300
Closed -$4.54M – 3514
2015
Q1 		$4.54M Sell
26,300
-3,700
-12% -$564K 0.03% 460
2014
Q4 		$3.88M Buy
+30,000
New +$3.87M 0.02% 499

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Group's UTHR Position: Q3 2021 in Review

Jefferies Group sold out of United Therapeutics (UTHR) in Q3 2021, closing a stake of 1,390 shares — an estimated $249K sold.

Jefferies Group first reported a position in UTHR in Q3 2014 and held it in 17 quarters. The position peaked at $5.67M in Q4 2017. 426 funds tracked by Wall St. Rank hold UTHR as of Q3 2021.

  • Jefferies Group reported no remaining United Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 1,390 United Therapeutics shares in Q3 2021, an estimated $249K.
  • Jefferies Group first reported a position in United Therapeutics in Q3 2014 and held it in 17 quarters.
  • Jefferies Group's United Therapeutics position peaked at $5.67M in Q4 2017.
  • 426 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.